Radiation‐induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? “A narrative review”-Reference-Cited by-同舟云学术

Radiation‐induced nausea and vomiting in head and neck cancer: Is it something worth considering in the intensity modulated radiotherapy era? “A narrative review”

Published:2019-10-21 Issue:1 Volume:42 Page:131-137
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Paiar Fabiola¹^ORCID,Cristaudo Agostino²,Gonnelli Alessandra¹,Giannini Noemi¹,Cocuzza Paola¹,Montrone Sabrina¹,Bruschini Luca³,Pasqualetti Francesco¹,Ursino Stefano¹,Bonomo Pierluigi⁴^ORCID

Affiliation:

1. Department of Radiation OncologyAzienda Ospedaliera Universitaria Pisana, University of Pisa Pisa Italy

2. Department of Radiation OncologyAzienda Ospedaliero‐Universitaria di Ferrara Arcispedale S. Anna, University of Ferrara Ferrara Italy

3. ENT, Audiology and Phoniatric UnitAzienda Ospedaliera Universitaria Pisana, University of Pisa Pisa Italy

4. Department of Radiation OncologyAzienda Ospedaliero Universitaria Careggi, University of Florence Florence Italy

Publisher

Wiley

Subject

Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hed.25982

Reference38 articles.

1. Use of18F-Fludeoxyglucose–Positron Emission Tomography/Computed Tomography for Patient Management and Outcome in Oropharyngeal Squamous Cell Carcinoma

2. Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

3. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial

4. Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients

5. Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A simple prediction model for the risk of boron neutron capture therapy-induced nausea and vomiting in head and neck cancer;Radiotherapy and Oncology;2024-10

2. Extraoral photobiomodulation to prevent hyposalivation in patients treated with head and neck radiotherapy: randomized double-blind clinical trial;2024-07-22

3. Nutrition in HNSCC: is it a matter for oncologists? The role of multidisciplinary team—a narrative literature review;Frontiers in Oncology;2024-07-03

4. Impact of fosaprepitant in the prevention of nausea and emesis in head and neck cancer patients undergoing cisplatin-based chemoradiation: a pilot prospective study and a review of literature;La radiologia medica;2024-02-14

5. Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy–Induced Nausea and Vomiting;JAMA Network Open;2023-07-27